Viewing StudyNCT06029257



Ignite Creation Date: 2024-05-06 @ 7:28 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06029257
Status: RECRUITING
Last Update Posted: 2024-01-31
First Post: 2023-09-01

Brief Title: A Study of Tildrakizumab in the Treatment of Genital Psoriasis CZATCH-Genital-PsO
Sponsor:
Organization: Almirall SA

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 110
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
98749
Who Masked List: